Search

everythinglearnresearchcommunity

for

Search:↓

Lichen Planus is a less common condition affecting skin and mucous membranes, with various types and associated risk factors, challenging to diagnose, significantly impacts life quality, and may have a risk of cancerous changes in oral lesions.

Transplant success has improved with better immunosuppressive drugs and donor matching.

Researchers found a specific immune receptor in patients that causes severe skin reactions to a drug.

The FOXN1 gene is crucial for developing immune cells and preventing immune disorders.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

Current and future treatments for alopecia areata focus on immunosuppression, immunomodulation, and protecting hair follicles.

Behçet's Disease may be caused by genetic and environmental factors leading to abnormal immune responses, and stress management and new treatments could improve patient outcomes.

New treatments for immune disorders caused by FOXN1 deficiency are promising.

Lower CD200R1 on certain immune cells is linked to more severe rheumatoid arthritis and immune imbalance.

Acne is significantly influenced by genetics, and understanding its genetic basis could lead to better, targeted treatments.

The skin and thymus develop similarly to protect and support immunity.

New treatments for hair loss show promise, but more research is needed to confirm their safety and effectiveness.

Genetic variants linked to ten skin diseases were found, showing both immune and non-immune factors play a role.

Alopecia areata involves immune response and gene changes affecting hair loss.

The document concludes that pregnancy and cancer share immune evasion tactics, but more research is needed before using checkpoint blockade immunotherapy in pregnant cancer patients to avoid harm to the placenta.

Immune checkpoint inhibitors can cause skin issues but are linked to better cancer outcomes.

Men are more likely to have severe respiratory viral infections like COVID-19 due to hormonal and genetic differences, while women generally have stronger immune responses.

Human prenatal skin develops an immune network early on that helps with skin formation and healing without scarring.

Alopecia Areata is an autoimmune condition causing hair loss, influenced by genetics, environment, and possibly improved by anti-MIF therapy, with many patients experiencing regrowth within a year.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

Skin bacteria can help wound healing by activating certain immune cells.

Small molecule DMF improves psoriasis and multiple sclerosis, adult skin cells can be made to grow new hair, certain skin cells initiate hair growth, IL-17C controls gut health and can cause skin inflammation, and skin cells produce IL-17 that can lead to psoriasis.

Hair regrowth was seen in 83% of children with alopecia, immune system plays a role in the condition, and various treatments showed effectiveness for hair and nail disorders.

Both Th1 and Th2 immune responses are increased in alopecia areata, with Th2 response more strongly linked to how severe the disease is.

Stress can cause hair loss by negatively affecting hair follicles and this effect might be reversed with specific treatments.

JAK inhibitors help with skin conditions but need more research on dosing and safety.

TRPV3 in skin cells causes inflammation and cell death.

A deficiency in the TTC7A gene causes immune problems, gut issues, and hair loss.

Alopecia areata involves immune system imbalances that may lead to depression and anxiety.

RANK is a key target in breast cancer treatment due to its role in tumor growth and bone metastasis.